Andrew J. Schwab - Mar 13, 2024 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director, 10%+ Owner
Signature
/s/ Andrew J. Schwab
Stock symbol
SKYE
Transactions as of
Mar 13, 2024
Transactions value $
$4,500,000
Form type
4
Date filed
3/15/2024, 04:15 PM
Previous filing
Mar 4, 2024
Next filing
Sep 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SKYE Common Stock Award $4.5M +450K +5.66% $10.00 8.39M Mar 13, 2024 By 5AM Ventures VII, L.P. F1
holding SKYE Common Stock 1.72M Mar 13, 2024 By 5AM Ventures II, L.P. F2
holding SKYE Common Stock 67.8K Mar 13, 2024 By 5AM Co-Investors II, L.P. F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. The Reporting Person is a managing member of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F2 The securities are directly held by 5AM Ventures II, L.P. ("Ventures II"). 5AM Partners II, LLC ("Partners II") is the sole general partner of Ventures II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F3 The securities are directly held by 5AM Co-Investors II, L.P. ("Co-Investors II"). Partners II is the sole general partner of Co-Investors II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.